Reduction of NOx from combustion flue gases bysuperimposed barrier discharge plasma reactors

NO_x reduction from combustion flue gases by superimposed barrier discharge plasma reactors is experimentally investigated. The experiments are conducted for applied voltages from 0 to 28 kV, flue gas rates from 0.5 to 2 L/min, ammonia mixture concentrations from 0.7 to 2.65 stoichiometry, and applied voltage phase differences from 0° to 180°, where two 60-Hz AC power supplies are used. The results show the following: (1) NO_x reduction rate decreases with increasing discharge power for surface discharge operations, however, NO_x reduction rate increases with increasing discharge power for silent and superimposing discharge operating modes; (2) NO_x reduction rate increases with increasing discharge power, gas flow rate and ammonia stoichiometry under in-phase operations; (3) NO_x reduction rate for out-of-phase operations is much higher compared with in-phase operations, however, NO_x reduction rate has an optimum condition on ammonia stoichiometry, discharge power, and gas flow rate; and (4) energy efficiency of NO_x reduction increases with increasing ammonia mixture and gas flow rate and decreases with increasing discharge power     

Removal of volatile organic compounds from air streams andindustrial flue gases by non-thermal plasma technology

Gaseous pollution control technologies for acid gases (NO_x , SO_x, etc.), volatile organic compounds (VOC), greenhouse gases, ozone layer depleting substance (ODS), etc., have been commercialized based on catalysis, incineration and adsorption methods. However, non-thermal plasma techniques based on electron beams and corona discharges become significant due to advantages such as lower cost, higher removal efficiency, smaller space volume, etc. In order to commercialize this new technology, the following needs faster investigation: pollution gas removal rates, energy efficiency of removal, pressure drop of reactors, usable byproduct production rates, identification of major fundamental processes, and optimization of reactor and power supply for an integrated system. In this work, recent development of gaseous pollution control technology based on discharge plasmas is reviewed critically and the principle of processes and reactor technologies are outlined     

Adenovirus vector-based purging of multiple myeloma cells

Adenoviruses are efficient gene delivery agents for a variety of neoplasms. In the present study, we have investigated the use of adenoviruses for the delivery of the thymidine kinase (tk) gene into multiple myeloma (MM) cells. We first demonstrated that MM cell lines and MM patient cells express both adenovirus receptors as well as the DF3/MUC1 protein, thus providing a rationale for using adenoviruses to selectively deliver genes under the control of the DF3 promoter. By using an adenoviral construct containing beta-galactosidase (beta-gal) gene driven by the DF3 promoter (Ad. DF3-betagal), we demonstrate greater than 80% transduction efficiency in OCI-My5 and RPMI 8226 MM cell lines at a multiplicity of infection of 1 to 100. Importantly, transduction with the tk gene driven by the DF3 promoter (Ad.DF3-tk) followed by treatment with 50 micromol/L ganciclovir (GCV) purged >/=6 log of contaminating OCI-My5 and RPMI 8226 MM cells within bone marrow mononuclear cells. In contrast, normal human hematopoietic progenitor cell number was unaffected under these conditions. Selectivity of DF3/MUC1 promoter was further confirmed, because Ad.DF3-betagal or Ad.DF3-tk did not transduce MUC1-negative HeLa cervical carcinoma cells. In addition, GCV treatment of Ad.DF3-tk-transduced RPMI 8226 MM cells did not induce a significant bystander effect. These findings demonstrate that transduction with Ad vectors using a tumor-selective promoter provides a highly efficient and selective approach for the ex vivo purging of MM cells.     

Dielectric Liquid-in-Liquid Dispersion by Applying Pulsed Voltage

Liquid-in-liquid dispersion, such as organic liquid in water or water in organic liquid, has been performed using dc or ac voltage applied between nozzle and ground electrode. In the present study, pulsed high voltage was applied to produce droplets with controlled diameter in wide range. The high voltage pulse source was capacitor discharge type with 20 - 50 Hz and ranged from 0 to several kV. Water glass was atomized in alcohol solution into diameters ranging from several mum to sub-mm, depending on applied voltage. The atomized water glass droplets were solidified by removing water molecules from the water glass. Synchronized droplet formation with pulse frequency was possible by controlling pulse voltage, width and frequency, which produced uniform sized droplets successively. When the pulse voltage was raised, the droplet formation mode changed from the synchronized formation to dispersion mode through transient mode. In the dispersion mode, droplets of several mum diameter having high uniformity were produced. Utilization of high voltage and high-speed pulse to liquid-liquid dispersion could make it possible to atomize in a conductive liquid without electrolysis.     

Changes in the Mechanical Properties of Silk Fabrics Modified with Epoxide and Their Relation to the Fabric Construction

An investigation is described in which the mechanical properties of silk fabrics treated with ethyleneglycol diglycidylether (EDGE) were measured in relation to variations in fabric structure in terms of weight gain. Their mechanical behaviour was determined in bending, in-plane shear, and compressional characteristics experiments. An examination of the mechanical properties of silk fabrics treated with EDGE led to the following conclusions. The value of the bending rigidity (B) in the weft direction clearly increased with an increase in weight gain, which suggested hardening of fabric. The value of the shearing stiffness (G) of the fabric in the warp direction remained unchanged in spite of the epoxide treatment, and the values of the shearing hysteresis (2HG) were linearly related to the weight gain. These results suggest that the observed changes in mechanical behaviour can be largely attributed to an increase in the contact pressure between warp and weft yarns.     

Removal of NF3 from semiconductor-process flue gases bytandem packed-bed plasma and adsorbent hybrid systems

A tandem hybrid gas cleanup system, consisting of a BaTiO₃ packed-bed plasma reactor and a CaCO₃ adsorbent filter, was used to study the removal of NF₃ from semiconductor-process flue gases. Plasma-chemical kinetics of N₂ -NF₃-O₂-H₂ gas mixtures suggested byproducts observed in the experiments. The laboratory-scale system showed NF₃ removal at atmospheric pressure. Typically, 100% NF₃ abatement was achieved with an inlet concentration of 5000 ppm and a gas residence time in the reactor less than 10 s     

Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease

It has been reported that serum hyaluronate [hyaluronic acid (HA)] concentrations are increased in liver diseases, especially in alcoholic liver disease (ALD). However, the characteristics of serum HA concentration in patients with ALD have not been studied. In this study, first, we measured serum HA concentrations in patients with different stages of both ALD and non-ALD to clarify the characteristics of serum HA concentration in patients with ALD. Second, we measured serum HA concentrations in patients with ALD sequentially after abstinence. We also measured serum HA concentrations in patients with chronic type C hepatitis before and after treatment with interferon. Finally, we analyzed the relationship between serum HA concentrations and the contents of type IV collagen and laminin in the livers of both ALD and non-ALD patients. Serum HA concentrations in liver disease were higher than the cut-off value, and increased significantly (p < 0.001) in parallel with the progression of hepatic fibrosis in both ALD and non-ALD patients. Serum HA concentrations in patients actively drinking with ALD were significantly higher (p < 0.001) than those in non-ALD. After 4 weeks of abstinence, these concentrations fell to the levels of non-ALD. Although serum ALT levels were decreased in 80% of patients treated with interferon, serum HA concentrations were not changed or increased. A significant correlation between serum HA concentrations and hepatic type IV collagen and laminin content was present in ALD, but not in non-ALD. These results clearly suggest that the increase of serum HA concentrations in ALD may be associated with not only hepatic fibrosis, but also alcohol drinking.     

MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells

The murine double minute 2 (MDM2) protein facilitates G1 to S phase transition by activation of E2F-1 and can enhance cell survival by suppressing wild-type p53 (wtp53) function. In this study, we examined MDM2 expression and function in multiple myeloma (MM) cells. MDM2 is strongly and constitutively expressed in MM cell lines (ARH-77, RPMI 8226, and OCI-My5) and in the cells of plasma cell leukemia (PCL) patients, but is not expressed in normal bone marrow mononuclear cells (BM MNCs). Treatment of MM cells with MDM2 antisense, but not sense, nonsense, or scrambled, oligodeoxyribonucleotides (ODNs) decreased DNA synthesis and cell viability; it also induced G1 growth arrest, as evidenced by propidium iodide (PI) staining and induction of retinoblastoma protein (pRB) to E2F-1 binding. Moreover, inhibition of MDM2 using antisense ODNs also triggered MM cell apoptosis as evidenced by acridine orange-ethidium bromide staining. We next studied the association of MDM2 with wtp53 and/or mutant p53 (mtp53), E2F-1, CDK4, and p21. MDM2 constitutively binds to E2F-1 in all MM cells, to both wtp53 and mtp53, and to p21 in tumor cells lacking p53. These data suggest that MDM2 may enhance cell-cycle progression in MM cells both by activating E2F-1 and by downregulating cell-cycle inhibitory proteins (wtp53 and p21). Overexpression of MDM2 may therefore contribute to both growth and survival of MM cells, suggesting the potential utility of treatment strategies targeting MDM2 in MM.     

Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia

Loss of p16(INK4A) (p16) expression is frequently associated with the development of epithelial and lymphoid malignancies. However, the frequency and significance of p16 abnormalities in multiple myeloma (MM) and the more aggressive phase of plasma cell leukemia (PCL) have not been well defined. Accordingly, the goal of this study was to define the expression and function of p16 in fresh samples of MM and PCL. We found that p16 protein was highly expressed in primary MM cells, although it was undetectable in fresh samples of PCL. Additionally, p16 protein was also absent in four of four MM-derived cell lines. To determine the mechanism for p16 underexpression in PCL and MM-derived cell lines, we performed PCR analysis to evaluate both gene deletion and the presence of methylation. Interestingly, the p16 gene was present and methylated in all patient PCL cells and MM cell lines, whereas it was unmethylated in patient MM cells and normal B cells. Furthermore, treatment with the demethylating agent 5-deoxyazacytidine or p16 retrofection restored p16 protein expression and induced G1 growth arrest in patient PCL cells and MM cell lines. These results suggest that inactivation of the p16 gene by methylation may be associated with decreased growth control and the development of PCL in a subset of patients with MM.     

Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone

Monoclonal antibodies (MoAbs) that selectively identify Muc-1 core protein (MoAbs DF3-P, VU-4H5) determinants were used to identify the Muc-1 glycoform present on 7 multiple myeloma (MM) cell lines, 5 MM patient plasma cells, 12 MM patient B cells, as well as 32 non-MM cell lines and normal hematopoietic cells. Flow cytometry studies demonstrated that all MM cell lines, MM patient plasma cells, and MM patient B cells expressed Muc-1 core protein epitopes. Circulating B cells from 4 normal donors also expressed Muc-1 core protein. In contrast, Muc-1 core protein was absent on 28 of 32 non-MM neoplastic cell lines, 17 of which expressed Muc-1. Splenic and tonsillar B cells, CD34(+) stem cells, resting T cells, and bone marrow plasma cells obtained from normal donors both lacked Muc-1 glycoforms. We next studied the effects of estrogen, progesterone, and glucocorticoid receptor agonists and antagonists on Muc-1 expression, because consensus sequences for the response elements of these steroids are present on the Muc-1 gene promoter. These studies showed that dexamethasone (Dex) induced Muc-1 expression on MM cell lines, as determined by both flow cytometry and Western blot analyses. Dex also induced upregulation of Muc-1 on prostate and ovarian cancer cell lines. Time and dose-response studies demonstrated that Dex induced maximal cell surface Muc-1 expression by 24 hours at concentrations of 10(-8) mol/L. Dex induced Muc-1 upregulation could be blocked with a 10-fold excess of the glucocorticoid receptor antagonist RU486, confirming that Dex was acting via the glucocorticoid receptor. No changes in Muc-1 expression were observed on MM cells treated with estrogen and progesterone receptor agonists and antagonists or with RU486. These studies provide the framework for targeting Muc-1 core protein in vaccination and serotherapy trials in MM. In addition, the finding that Muc-1 expression on MM cells can be augmented by Dex at pharmacologically achievable levels suggests their potential utility in enhancing treatments targeting Muc-1 in MM.